Release Date: February 9, 2026
Expiration Date: March 16, 2026
Activity Overview
This educational activity is an archive of the live presentation held on January 25, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in lung cancers and breast cancers. Other health care professionals interested in the treatment of these malignancies are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate biomarkers, genomic assays, and other molecular testing tools into the development of personalized treatment plans for patients with breast cancer
- Assess clinical trial evidence for current and emerging systemic therapies for use in the management of early-stage and advanced/metastatic breast cancer
- Develop individualized treatment plans for patients with early-stage and advanced/metastatic breast cancer by incorporating high-level clinical trial evidence with tumor- and patient-specific factors
- Develop strategies to minimize or prevent treatment-related AEs in patients receiving treatment for breast cancer to improve adherence and patient outcomes
Hope S. Rugo, MD, FASCO
Director,
Women’s Cancers Program
Division
Chief, Breast Medical Oncology
Professor,
Department of Medical Oncology & Therapeutics Research
City
of Hope Comprehensive Cancer Center
Duarte,
CA
Professor
Emeritus, UCSF
Naoto T. Ueno, MD, PhD
Professor
of Medicine
Director,
University of Hawaiʻi Cancer Center
John
A. Burns School of Medicine
University
of Hawaiʻi at Mānoa
Honolulu,
HI
Benjamin Falit, MD
Radiation
Oncologist and Medical Director
Pacific
Cancer Institute
Wailuku,
HI
Jami Fukui, MD
Associate
Professor/Researcher
Cancer
Biology—Translational and
Clinical
Research
University
of Hawaiʻi Cancer Center
John
A. Burns School of Medicine
University
of Hawaiʻi at Mānoa
Honolulu,
HI
Laura Huppert, MD
Assistant
Professor of Medicine
Division
of Hematology/Oncology
University
of California San Francisco
San Francisco, CA
Sara A. Hurvitz, MD, FACP
Professor of Medicine
Head, Division of Hematology and Oncology
University of Washington Medicine
Senior Vice President, Clinical Research Division
Fred Hutch Cancer Center
Seattle, WA
Jodi Kagihara, MD
Assistant Professor
John A. Burns School of Medicine
University of Hawai‘i
Hematologist/Medical Oncologist
Hawaii Oncology, Inc
Director of Medical Education
Kuakini Medical Center
Honolulu, HI
Irene Kang, MD
Assistant Professor, Division of Medical Oncology and Therapeutics
Research
Medical Director, Women’s Health
Breast Oncology
City of Hope Orange County
Irvine, CA
William Loui, MD, FACP
Medical Oncologist
Adventist Health
Kailua, HI
Ashley Marumoto, MD
Breast Surgical Oncologist
The Queen’s Medical Center
Honolulu, HI
Rebecca Shatsky, MD
Professor of Medicine
Breast Medical Oncology Team Leader
Director of Breast Cancer Clinical Trials
Director of Inflammatory and Triple-Negative Breast Cancer Program
University of California San Diego
San Diego, CA
Naoko Takebe, MD, PhD
Professor, Department of Medicine
Chief, Solid Tumor Oncology Section
Associate Director of Clinical Research
Nancy Johnston Records Chair in Oncology
Stephenson Cancer Center
University of Oklahoma
Oklahoma City, OK
Melinda Telli, MD, FASCO
Professor of Medicine
Stanford University School of Medicine
Director, Breast Cancer Program
Stanford Cancer Institute
Stanford, CA
Rachel Thelen, FNP-C, AOCNP
Oncology Certified Nurse Practitioner
Maui Health Outpatient Clinic, Oncology/Hematology
Wailuku, HI
Teruo Yamauchi, MD, MS
Professor, Translational and Clinical
Research/Cancer Biology Program
Faculty Leader of Clinical Education
University of Hawaiʻi Cancer Center
Honolulu, HI
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here